7701N Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Strong Balance SheetExtremely low leverage (debt-to-equity ~0.02) provides durable financial flexibility. It allows investment in R&D, capex or acquisitions and buffers downturns without forced asset sales or refinancing, supporting long-term strategic optionality and resilience.
Steady Revenue And Improving MarginsConsistent top-line growth (~3.7%) alongside rising gross (~44.6%) and EBIT (~13.1%) margins indicates resilient demand and pricing power in analytical and medical instruments. This combination supports sustainable cash generation and reinvestment capability over time.
Recurring Installed-base RevenueThe business model pairs upfront hardware sales with recurring services and consumables tied to an installed base. That creates durable, higher-margin annuity-like cash flows, reduces revenue cyclicality and increases lifetime customer value across product cycles.
Bears Say
Cash-flow VolatilityNotable year-to-year swings in operating and free cash flow, including a sharp 2024 dip, reduce predictability of internal funding. Working-capital or timing sensitivity can force higher liquidity buffers or short-term financing, constraining strategic agility.
Margin VariabilityAlthough margins improved recently, variability versus the 2024 peak highlights exposure to product-mix shifts and input-cost pressure. Persistent margin swings could cap sustainable profitability and make long-term earnings less certain.
Limited ROE MomentumThe note that ROE isn't accelerating suggests limited efficiency gains from asset turns or margin expansion. Even with a conservative balance sheet, constrained ROE momentum can limit shareholder-return upside absent sustained operational improvement.
7701N FAQ
What was Shimadzu Corporation’s price range in the past 12 months?
Currently, no data Available
What is Shimadzu Corporation’s market cap?
Shimadzu Corporation’s market cap is $130.92B.
When is Shimadzu Corporation’s upcoming earnings report date?
Shimadzu Corporation’s upcoming earnings report date is Aug 06, 2026 which is in 12 days.
How were Shimadzu Corporation’s earnings last quarter?
Shimadzu Corporation released its earnings results on May 12, 2026. The company reported $7.925 earnings per share for the quarter, beating the consensus estimate of $5.377 by $2.549.
Is Shimadzu Corporation overvalued?
According to Wall Street analysts Shimadzu Corporation’s price is currently Undervalued.
Does Shimadzu Corporation pay dividends?
Shimadzu Corporation does not currently pay dividends.
What is Shimadzu Corporation’s EPS estimate?
Shimadzu Corporation’s EPS estimate is 3.7.
How many shares outstanding does Shimadzu Corporation have?
Shimadzu Corporation has 296,070,250 shares outstanding.
What happened to Shimadzu Corporation’s price movement after its last earnings report?
Shimadzu Corporation reported an EPS of $7.925 in its last earnings report, beating expectations of $5.377. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Shimadzu Corporation?
Currently, no hedge funds are holding shares in MX:7701N
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Shimadzu Corporation
Shimadzu Corporation, founded in Kyoto, Japan, in 1875, is a global entity specializing in the development, production, and distribution of a diverse range of advanced instruments and systems. The company's extensive offerings span analytical and measuring instruments, medical systems, industrial machinery, and aviation equipment. Its analytical instrumentation segment provides comprehensive solutions including gas and liquid chromatography, gas and liquid chromatograph-mass spectrometry, molecular and elemental spectroscopy, and surface analysis. This division also manufactures life science laboratory instruments, total organic carbon analyzers, continuous monitoring analysis systems, thermal and particle size analysis equipment, materials testing and inspection devices, non-destructive testing apparatus, and precision balances, all supported by data management software. In the medical sector, Shimadzu delivers cutting-edge imaging technologies such as angiography, fluoroscopy, mobile C-arms, radiography and mobile X-ray systems, and fluorescence imaging products. The company further produces high-precision optical components, including diffraction gratings, aspherical mirrors, specialized laser mirrors and windows for high-power applications, polka-dot beam splitters, and accurate refractometers. For industrial use, Shimadzu offers machinery ranging from turbo molecular pumps, helium leak detectors, sputtering and multi-deposition systems, and vacuum heat-treatment furnaces. Their industrial portfolio also includes liquid delivery gear pumps, mechatronic systems like glass fiber winders and liquid crystal injection systems, and dynamic balancing machines, alongside hydraulic equipment such as hydraulic gear pumps, power packages, and multi-control valves. Additionally, the company supplies the aerospace industry with essential components including electro-mechanical actuators, advanced flight control systems, and landing gear systems.